Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Total Current Liabilities (2020 - 2025)

iHuman has reported Total Current Liabilities over the past 6 years, most recently at $51.3 million for Q4 2025.

  • Quarterly Total Current Liabilities fell 17.63% to $51.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.3 million through Dec 2025, down 17.63% year-over-year, with the annual reading at $52.0 million for FY2025, 15.11% down from the prior year.
  • Total Current Liabilities was $51.3 million for Q4 2025 at iHuman, down from $62.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $78.9 million in Q4 2022 and troughed at $51.3 million in Q4 2025.
  • The 5-year median for Total Current Liabilities is $68.2 million (2023), against an average of $67.2 million.
  • Biggest five-year swings in Total Current Liabilities: grew 25.39% in 2021 and later decreased 17.63% in 2025.
  • Tracing IH's Total Current Liabilities over 5 years: stood at $75.5 million in 2021, then rose by 4.44% to $78.9 million in 2022, then fell by 13.6% to $68.2 million in 2023, then decreased by 8.59% to $62.3 million in 2024, then decreased by 17.63% to $51.3 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $51.3 million, $62.3 million, and $68.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.